Bilateral testicular cancer

Although the case we described is not common, the incidence of testicular cancer, as well as bilateral testicular cancer, is rising. The primary care physician can help reduce morbidity in these patients by encouraging monthly self-examinations of the testicles and by paying attention to high-risk s...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of the American Board of Family Practice Vol. 7; no. 6; p. 516
Main Authors Bischof, Jr, E F, Herold, A H, Marty, P J
Format Journal Article
LanguageEnglish
Published United States 01.11.1994
Subjects
Adult
Carcinoma in Situ - diagnosis
Carcinoma in Situ - epidemiology
Carcinoma in Situ - radiotherapy
Humans
Lymph Node Excision
Male
Neoplasms, Second Primary - epidemiology
Neoplasms, Second Primary - pathology
Neoplasms, Second Primary - therapy
Orchiectomy
Seminoma - epidemiology
Seminoma - pathology
Seminoma - radiotherapy
Teratoma - epidemiology
Teratoma - pathology
Teratoma - therapy
Testicular Neoplasms - epidemiology
Testicular Neoplasms - pathology
Testicular Neoplasms - therapy
Online AccessGet more information

Cover

More Information
Summary:Although the case we described is not common, the incidence of testicular cancer, as well as bilateral testicular cancer, is rising. The primary care physician can help reduce morbidity in these patients by encouraging monthly self-examinations of the testicles and by paying attention to high-risk subgroups, such as those with a family history of testicular cancer, a personal history of cryptorchidism, infertility, or a contralateral testicular volume less than 12 mL. The primary care physician should, in at least these cases, discuss the option of a testicular biopsy to rule out CIS in the contralateral testicle. Treatment and follow-up options can then be explored to reduce further sequelae from this disease.
ISSN:0893-8652